Clinomics Inc - ESG Rating & Company Profile powered by AI
If you are employed by Clinomics Inc and you wish to use your ESG rating, please contact us. The page is a free ESG assessment covering Clinomics Inc. This report of Clinomics Inc incorporates data from across the web and also from public documents by Clinomics Inc.
Clinomics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Clinomics Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Clinomics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Clinomics Inc disclose current and historical energy intensity?
Does Clinomics Inc report the average age of the workforce?
Does Clinomics Inc reference operational or capital allocation in relation to climate change?
Does Clinomics Inc disclose its ethnicity pay gap?
Does Clinomics Inc disclose cybersecurity risks?
Does Clinomics Inc offer flexible work?
Does Clinomics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Clinomics Inc disclose the number of employees in R&D functions?
Does Clinomics Inc conduct supply chain audits?
Does Clinomics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Clinomics Inc conduct 360 degree staff reviews?
Does Clinomics Inc disclose the individual responsible for D&I?
Does Clinomics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Clinomics Inc disclose current and / or historical scope 2 emissions?
Does Clinomics Inc disclose water use targets?
Does Clinomics Inc have careers partnerships with academic institutions?
Did Clinomics Inc have a product recall in the last two years?
Does Clinomics Inc disclose incidents of discrimination?
Does Clinomics Inc allow for Work Councils/Collective Agreements to be formed?
Has Clinomics Inc issued a profit warning in the past 24 months?
Does Clinomics Inc disclose parental leave metrics?
Does Clinomics Inc disclose climate scenario or pathway analysis?
Does Clinomics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Clinomics Inc disclose the pay ratio of women to men?
Does Clinomics Inc support suppliers with sustainability related research and development?
Does Clinomics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Clinomics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Clinomics Inc involved in embryonic stem cell research?
Does Clinomics Inc disclose GHG and Air Emissions intensity?
Does Clinomics Inc disclose its waste policy?
Does Clinomics Inc report according to TCFD requirements?
Does Clinomics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Clinomics Inc disclose energy use targets?
Does Clinomics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Clinomics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Clinomics Inc
These potential risks are based on the size, segment and geographies of the company.
Clinomics Inc., a biotechnology company, provides genome-based cancer and disease diagnostic solutions. It provides TrioDx RT-PCR COVID-19 Test (FDA EUA), liquid biopsy and precision medicines, health care services, and big data solutions. The company's liquid biopsy and precision medicines include CD-PRIME, a platform that offers automated protocols for the enrichment of circulating tumor cells (CTCs), cell free DNA, and EV (exosome) derived from cancer tissues; Cancer-PRIME, a cancer gene analysis service for analyzing results related to precision medicine information with bioinformatics and the detection of various gene mutations; and BioViewCCBS, a scanning platform that helps in capturing cells inside the sample in 3D and in finding and analyzing CTC inside the sample. It also acts as the distributor and seller for AmoyDx's molecule diagnosis method kit in Korea, which is a diagnostics kit used to predict NSCLC patients' reactions to specific drug treatment; for Fluxion Biosciences' Spotlight 59 Panel that provides sensitive detection result with a design for mutated cell detection in cancer samples; and for Fluxion Biosciences' IsoFlux System, an analysis system for circulating tumor cells to extract rare cells to be used in the desired field of applications. In addition, the company provides health care services, such as Geno-P, which provides specialized genome information for 11 physical characteristics based on genome standard reference data; Geno-D that provides prediction services for probability of incidence of diseases; GenomeBook, which provides whole genome information; NIP10, an examination service that is possible after 10 weeks of pregnancy through non-invasive, pre-birth examination to detect fetal chromosome abnormalities; and biological age analysis service. Further, it provides BioComputer, which is an automated computing infrastructure solution to process genomic data. The company was founded in 2011 and is based in Ulsan, South Korea.